Anna Forsby
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Anna Forsby has a total of 256 co-authors. Here are the top co-authors by number of shared publications:
Jessica Lundqvist
Department of Biochemistry and Biophysics, Stockholm University, Stockholm, Sweden
7 shared publications- Marcel Leist
Department of in vitro toxicology and biomedicine, Faculty of Sciences, University of Konstanz, Konstanz, Germany
6 shared publications Erik Walum
5 shared publications- Paul Jennings
Department of Chemistry and Pharmaceutical Sciences, Vrije Universiteit Amsterdam, Amsterdam Institute of Molecular and Life Sciences (AIMMS), De Boelelaan 1108, 1081 HZ, Amsterdam, The Netherlands.
5 shared publications - Bas J. Blaauboer
Division of Toxicology, Institute for Risk Assessment Sciences, Utrecht University, Utrecht, The Netherlands
4 shared publications - Bob van de Water
Leiden University, Leiden Academic Centre for Drug Research, Division of Cell Systems and Drug Safety, Leiden, The Netherlands
4 shared publications
Latest Publications
- Open Access
- 25 September 2026
- Published by ALTEX Edition in ALTEX
Linking nuclear receptor antagonism with neuronal morphology improves detection of developmental neurotoxicants
Brain development is highly dependent on hormonal signaling, hence developmental exposure to endocrine disrupting chemicals (EDCs) is of high concern. However, existing EDC hazard assessment methods lack the capacity to connect developmental neurotoxicity (DNT) to an endocrine mode of action, creating an urgent need for innovative tools addressing endocrine disruption (ED)-induced DNT. We have previously shown the applicability of the immortalized C17.2 murine neural progenitor cells for addressing ED-DNT. In this test sys-tem, the key neurodevelopmental processes (KNDPs) neurite outgrowth and branching were decreased by agonism of retinoic acid receptor (RAR), retinoic X receptor (RXR) and peroxisome proliferator-activated recep-tor (PPAR) β/δ. In the current study we further validate the use, and assess the added value, of the C17.2 test system for detection of ED-induced DNT by testing the effects of 17 chemicals on neuronal morphology and comparing the results to published DNT in vitro toxicity data. Out of the tested chemicals, endosulfan and cy-permethrin decreased neurite outgrowth and branching when tested alone. However, while permethrin, bi-sphenol F (BPF), benzyl butyl phthalate (BBzP) and its metabolite MBzP, perfluorooctanesulfonic acid (PFOS), and 3-phenoxybenzoic acid (3-PBA) did not independently reduce neurite outgrowth, they counteracted RAR, RXR or PPARβ/δ agonist-induced decreases, indicating antagonistic activity. Compared to neurite morphology-related endpoints in ToxCast, C17.2 cells identified more chemicals as active, with increased sensitivity to this endpoint category. These findings confirm that the C17.2 test system is a valuable in vitro model for detecting ED-induced DNT, and that receptor agonist co-treatment enables identification of additional DNT compounds. Plain language summaryChemicals in our environment can interfere with the body’s hormonal system and harm brain development, particularly in children. Identifying which chemicals pose this risk is challenging because current testing meth-ods are limited in their ability to connect hormone disruption to developmental brain damage. The current study demonstrated that a cell-based model, C17.2 cells, can reliably detect chemicals that disrupt hormonal path-ways linked to abnormal brain development. By observing the morphology of these cells, we can identify both chemicals that activate and those that block hormonal signals. The C17.2 model addresses a critical gap in current guidelines for assessing hormone-disrupting chemicals while reducing and replacing the need for ani-mal testing in line with the 3R principles, making it a valuable tool for improving chemical safety assessment and protecting public health.
- 25 September 2026
- Published by ALTEX Edition in ALTEX
Open AccessLinking nuclear receptor antagonism with neuronal morphology improves detection of developmental neurotoxicants
Brain development is highly dependent on hormonal signaling, hence developmental exposure to endocrine disrupting chemicals (EDCs) is of high concern. However, existing EDC hazard assessment methods lack the capacity to connect developmental neurotoxicity (DNT) to an endocrine mode of action, creating an urgent need for innovative tools addressing endocrine disruption (ED)-induced DNT. We have previously shown the applicability of the immortalized C17.2 murine neural progenitor cells for addressing ED-DNT. In this test sys-tem, the key neurodevelopmental processes (KNDPs) neurite outgrowth and branching were decreased by agonism of retinoic acid receptor (RAR), retinoic X receptor (RXR) and peroxisome proliferator-activated recep-tor (PPAR) β/δ. In the current study we further validate the use, and assess the added value, of the C17.2 test system for detection of ED-induced DNT by testing the effects of 17 chemicals on neuronal morphology and comparing the results to published DNT in vitro toxicity data. Out of the tested chemicals, endosulfan and cy-permethrin decreased neurite outgrowth and branching when tested alone. However, while permethrin, bi-sphenol F (BPF), benzyl butyl phthalate (BBzP) and its metabolite MBzP, perfluorooctanesulfonic acid (PFOS), and 3-phenoxybenzoic acid (3-PBA) did not independently reduce neurite outgrowth, they counteracted RAR, RXR or PPARβ/δ agonist-induced decreases, indicating antagonistic activity. Compared to neurite morphology-related endpoints in ToxCast, C17.2 cells identified more chemicals as active, with increased sensitivity to this endpoint category. These findings confirm that the C17.2 test system is a valuable in vitro model for detecting ED-induced DNT, and that receptor agonist co-treatment enables identification of additional DNT compounds. Plain language summaryChemicals in our environment can interfere with the body’s hormonal system and harm brain development, particularly in children. Identifying which chemicals pose this risk is challenging because current testing meth-ods are limited in their ability to connect hormone disruption to developmental brain damage. The current study demonstrated that a cell-based model, C17.2 cells, can reliably detect chemicals that disrupt hormonal path-ways linked to abnormal brain development. By observing the morphology of these cells, we can identify both chemicals that activate and those that block hormonal signals. The C17.2 model addresses a critical gap in current guidelines for assessing hormone-disrupting chemicals while reducing and replacing the need for ani-mal testing in line with the 3R principles, making it a valuable tool for improving chemical safety assessment and protecting public health.
- Open Access
- 18 October 2024
- Published by MDPI AG in Pharmaceuticals
- Vol. 17 (10) , 1392
Assessing the Neurodevelopmental Impact of Fluoxetine, Citalopram, and Paroxetine on Neural Stem Cell-Derived Neurons
Background/Objectives: Many pregnant women globally suffer from depression and are routinely prescribed selective serotonin reuptake inhibitors (SSRIs). These drugs function by blocking the re-uptake of serotonin by the serotonin transporter (SERT) into neurons, resulting in its accumulation in the presynaptic cleft. Despite a large amount of research suggesting a potential link to neurodevelopmental disorders in children whose mothers took these drugs during pregnancy, their possible adverse effects are still debated, and results are contradictory. On the other hand, there is an immediate need for improved cell-based models for developmental neurotoxicity studies (DNT) to minimize the use of animals in research. Methods: In this study, we aimed to assess the effects of clinically relevant concentrations of paroxetine (PAR), fluoxetine (FLX), and citalopram (CIT)—on maturing neurons derived from human neural stem cells using multiple endpoints. Results: Although none of the tested concentrations of FLX, CIT, or PAR significantly affected cell viability, FLX (10 µM) exhibited the highest reduction in viability compared to the other drugs. Regarding neurite outgrowth, CIT did not have a significant effect. However, FLX (10 µM) significantly reduced both mean neurite outgrowth and mean processes, PAR significantly reduced mean processes, and showed a trend of dysregulation of multiple genes associated with neuronal development at therapeutic-relevant serum concentrations. Conclusions: Transcriptomic data and uptake experiments found no SERT activity in the system, suggesting that the adverse effects of FLX and PAR are independent of SERT.
- 18 October 2024
- Published by MDPI AG in Pharmaceuticals
- Vol. 17 (10) , 1392
Open AccessAssessing the Neurodevelopmental Impact of Fluoxetine, Citalopram, and Paroxetine on Neural Stem Cell-Derived Neurons
Background/Objectives: Many pregnant women globally suffer from depression and are routinely prescribed selective serotonin reuptake inhibitors (SSRIs). These drugs function by blocking the re-uptake of serotonin by the serotonin transporter (SERT) into neurons, resulting in its accumulation in the presynaptic cleft. Despite a large amount of research suggesting a potential link to neurodevelopmental disorders in children whose mothers took these drugs during pregnancy, their possible adverse effects are still debated, and results are contradictory. On the other hand, there is an immediate need for improved cell-based models for developmental neurotoxicity studies (DNT) to minimize the use of animals in research. Methods: In this study, we aimed to assess the effects of clinically relevant concentrations of paroxetine (PAR), fluoxetine (FLX), and citalopram (CIT)—on maturing neurons derived from human neural stem cells using multiple endpoints. Results: Although none of the tested concentrations of FLX, CIT, or PAR significantly affected cell viability, FLX (10 µM) exhibited the highest reduction in viability compared to the other drugs. Regarding neurite outgrowth, CIT did not have a significant effect. However, FLX (10 µM) significantly reduced both mean neurite outgrowth and mean processes, PAR significantly reduced mean processes, and showed a trend of dysregulation of multiple genes associated with neuronal development at therapeutic-relevant serum concentrations. Conclusions: Transcriptomic data and uptake experiments found no SERT activity in the system, suggesting that the adverse effects of FLX and PAR are independent of SERT.
- Open Access
- 28 March 2024
- Published by Elsevier in Food and Chemical Toxicology
- Vol. 187, 114623
Attenuated neuronal differentiation caused by acrylamide is not related to oxidative stress in differentiated human neuroblastoma SH-SY5Y cells
- 28 March 2024
- Published by Elsevier in Food and Chemical Toxicology
- Vol. 187, 114623
Open AccessAttenuated neuronal differentiation caused by acrylamide is not related to oxidative stress in differentiated human neuroblastoma SH-SY5Y cells
- Open Access
- 23 June 2023
- Published by Springer Nature in Cell Biology and Toxicology
- Vol. 39 (6) , 3031-3059
Transcriptional landscape of mitochondrial electron transport chain inhibition in renal cells
Analysis of the transcriptomic alterations upon chemical challenge, provides in depth mechanistic information on the compound’s toxic mode of action, by revealing specific pathway activation and other transcriptional modulations. Mapping changes in cellular behaviour to chemical insult, facilitates the characterisation of chemical hazard. In this study, we assessed the transcriptional landscape of mitochondrial impairment through the inhibition of the electron transport chain (ETC) in a human renal proximal tubular cell line (RPTEC/TERT1). We identified the unfolded protein response pathway (UPR), particularly the PERK/ATF4 branch as a common cellular response across ETC I, II and III inhibitions. This finding and the specific genes elaborated may aid the identification of mitochondrial liabilities of chemicals in both legacy data and prospective transcriptomic studies. Graphical abstract
- 23 June 2023
- Published by Springer Nature in Cell Biology and Toxicology
- Vol. 39 (6) , 3031-3059
Open AccessTranscriptional landscape of mitochondrial electron transport chain inhibition in renal cells
Analysis of the transcriptomic alterations upon chemical challenge, provides in depth mechanistic information on the compound’s toxic mode of action, by revealing specific pathway activation and other transcriptional modulations. Mapping changes in cellular behaviour to chemical insult, facilitates the characterisation of chemical hazard. In this study, we assessed the transcriptional landscape of mitochondrial impairment through the inhibition of the electron transport chain (ETC) in a human renal proximal tubular cell line (RPTEC/TERT1). We identified the unfolded protein response pathway (UPR), particularly the PERK/ATF4 branch as a common cellular response across ETC I, II and III inhibitions. This finding and the specific genes elaborated may aid the identification of mitochondrial liabilities of chemicals in both legacy data and prospective transcriptomic studies. Graphical abstract
- Open Access
- 18 May 2023
- Published by Elsevier in NeuroToxicology
- Vol. 97, 65-77
Evaluation of mRNA markers in differentiating human SH-SY5Y cells for estimation of developmental neurotoxicity
- 18 May 2023
- Published by Elsevier in NeuroToxicology
- Vol. 97, 65-77
Open AccessEvaluation of mRNA markers in differentiating human SH-SY5Y cells for estimation of developmental neurotoxicity
- Open Access
- 13 October 2021
- Published by Springer Nature in Archives of Toxicology
- Vol. 96 (1) , 259-285
Mapping the cellular response to electron transport chain inhibitors reveals selective signaling networks triggered by mitochondrial perturbation
Mitochondrial perturbation is a key event in chemical-induced organ toxicities that is incompletely understood. Here, we studied how electron transport chain (ETC) complex I, II, or III (CI, CII and CIII) inhibitors affect mitochondrial functionality, stress response activation, and cell viability using a combination of high-content imaging and TempO-Seq in HepG2 hepatocyte cells. CI and CIII inhibitors perturbed mitochondrial membrane potential (MMP) and mitochondrial and cellular ATP levels in a concentration- and time-dependent fashion and, under conditions preventing a switch to glycolysis attenuated cell viability, whereas CII inhibitors had no effect. TempO-Seq analysis of changes in mRNA expression pointed to a shared cellular response to CI and CIII inhibition. First, to define specific ETC inhibition responses, a gene set responsive toward ETC inhibition (and not to genotoxic, oxidative, or endoplasmic reticulum stress) was identified using targeted TempO-Seq in HepG2. Silencing of one of these genes, NOS3, exacerbated the impact of CI and CIII inhibitors on cell viability, indicating its functional implication in cellular responses to mitochondrial stress. Then by monitoring dynamic responses to ETC inhibition using a HepG2 GFP reporter panel for different classes of stress response pathways and applying pathway and gene network analysis to TempO-Seq data, we looked for downstream cellular events of ETC inhibition and identified the amino acid response (AAR) as being triggered in HepG2 by ETC inhibition. Throughin silicoapproaches we provide evidence indicating that a similar AAR is associated with exposure to mitochondrial toxicants in primary human hepatocytes. Altogether, we (i) unravel quantitative, time- and concentration-resolved cellular responses to mitochondrial perturbation, (ii) identify a gene set associated with adaptation to exposure to active ETC inhibitors, and (iii) show that ER stress and an AAR accompany ETC inhibition in HepG2 and primary hepatocytes.
- 13 October 2021
- Published by Springer Nature in Archives of Toxicology
- Vol. 96 (1) , 259-285
Open AccessMapping the cellular response to electron transport chain inhibitors reveals selective signaling networks triggered by mitochondrial perturbation
Mitochondrial perturbation is a key event in chemical-induced organ toxicities that is incompletely understood. Here, we studied how electron transport chain (ETC) complex I, II, or III (CI, CII and CIII) inhibitors affect mitochondrial functionality, stress response activation, and cell viability using a combination of high-content imaging and TempO-Seq in HepG2 hepatocyte cells. CI and CIII inhibitors perturbed mitochondrial membrane potential (MMP) and mitochondrial and cellular ATP levels in a concentration- and time-dependent fashion and, under conditions preventing a switch to glycolysis attenuated cell viability, whereas CII inhibitors had no effect. TempO-Seq analysis of changes in mRNA expression pointed to a shared cellular response to CI and CIII inhibition. First, to define specific ETC inhibition responses, a gene set responsive toward ETC inhibition (and not to genotoxic, oxidative, or endoplasmic reticulum stress) was identified using targeted TempO-Seq in HepG2. Silencing of one of these genes, NOS3, exacerbated the impact of CI and CIII inhibitors on cell viability, indicating its functional implication in cellular responses to mitochondrial stress. Then by monitoring dynamic responses to ETC inhibition using a HepG2 GFP reporter panel for different classes of stress response pathways and applying pathway and gene network analysis to TempO-Seq data, we looked for downstream cellular events of ETC inhibition and identified the amino acid response (AAR) as being triggered in HepG2 by ETC inhibition. Throughin silicoapproaches we provide evidence indicating that a similar AAR is associated with exposure to mitochondrial toxicants in primary human hepatocytes. Altogether, we (i) unravel quantitative, time- and concentration-resolved cellular responses to mitochondrial perturbation, (ii) identify a gene set associated with adaptation to exposure to active ETC inhibitors, and (iii) show that ER stress and an AAR accompany ETC inhibition in HepG2 and primary hepatocytes.
- Open Access
- 7 October 2020
- Published by Springer Nature in Scientific Reports
- Vol. 10 (1) , 1-15
Acrylamide alters CREB and retinoic acid signalling pathways during differentiation of the human neuroblastoma SH-SY5Y cell line
Acrylamide (ACR) is a known neurotoxicant which crosses the blood–brain barrier, passes the placenta and has been detected in breast milk. Hence, early-life exposure to ACR could lead to developmental neurotoxicity. The aim of this study was to elucidate if non-cytotoxic concentrations of ACR alter neuronal differentiation by studying gene expression of markers significant for neurodevelopment in the human neuroblastoma SH-SY5Y cell model. Firstly, by using RNASeq we identified two relevant pathways that are activated during 9 days of retinoic acid (RA) induced differentiation i.e. RA receptor (RAR) activation and the cAMP response element-binding protein (CREB) signalling pathways. Next, by qPCR we showed that 1 and 70 µM ACR after 9 days exposure alter the expression of 13 out of 36 genes in the RAR activation pathway and 18 out of 47 in the CREB signalling pathway. Furthermore, the expression of established neuronal markers i.e. BDNF, STXBP2, STX3, TGFB1 and CHAT were down-regulated. Decreased protein expression of BDNF and altered ratio of phosphorylated CREB to total CREB were confirmed by western blot. Our results reveal that micromolar concentrations of ACR sustain proliferation, decrease neurite outgrowth and interfere with signalling pathways involved in neuronal differentiation in the SH-SY5Y cell model.
- 7 October 2020
- Published by Springer Nature in Scientific Reports
- Vol. 10 (1) , 1-15
Open AccessAcrylamide alters CREB and retinoic acid signalling pathways during differentiation of the human neuroblastoma SH-SY5Y cell line
Acrylamide (ACR) is a known neurotoxicant which crosses the blood–brain barrier, passes the placenta and has been detected in breast milk. Hence, early-life exposure to ACR could lead to developmental neurotoxicity. The aim of this study was to elucidate if non-cytotoxic concentrations of ACR alter neuronal differentiation by studying gene expression of markers significant for neurodevelopment in the human neuroblastoma SH-SY5Y cell model. Firstly, by using RNASeq we identified two relevant pathways that are activated during 9 days of retinoic acid (RA) induced differentiation i.e. RA receptor (RAR) activation and the cAMP response element-binding protein (CREB) signalling pathways. Next, by qPCR we showed that 1 and 70 µM ACR after 9 days exposure alter the expression of 13 out of 36 genes in the RAR activation pathway and 18 out of 47 in the CREB signalling pathway. Furthermore, the expression of established neuronal markers i.e. BDNF, STXBP2, STX3, TGFB1 and CHAT were down-regulated. Decreased protein expression of BDNF and altered ratio of phosphorylated CREB to total CREB were confirmed by western blot. Our results reveal that micromolar concentrations of ACR sustain proliferation, decrease neurite outgrowth and interfere with signalling pathways involved in neuronal differentiation in the SH-SY5Y cell model.
- 27 July 2020
- Published by Springer Nature in Archives of Toxicology
- Vol. 94 (8) , 2731-2732
Correction to: Multiparametric assessment of mitochondrial respiratory inhibition in HepG2 and RPTEC/TERT1 cells using a panel of mitochondrial targeting agrochemicals
- 27 July 2020
- Published by Springer Nature in Archives of Toxicology
- Vol. 94 (8) , 2731-2732
Correction to: Multiparametric assessment of mitochondrial respiratory inhibition in HepG2 and RPTEC/TERT1 cells using a panel of mitochondrial targeting agrochemicals
- Open Access
- 18 July 2020
- Published by Springer Nature in Archives of Toxicology
- Vol. 94 (8) , 2707-2729
Multiparametric assessment of mitochondrial respiratory inhibition in HepG2 and RPTEC/TERT1 cells using a panel of mitochondrial targeting agrochemicals
Evidence is mounting for the central role of mitochondrial dysfunction in several pathologies including metabolic diseases, accelerated ageing, neurodegenerative diseases and in certain xenobiotic-induced organ toxicity. Assessing mitochondrial perturbations is not trivial and the outcomes of such investigations are dependent on the cell types used and assays employed. Here we systematically investigated the effect of electron transport chain (ETC) inhibitors on multiple mitochondrial-related parameters in two human cell types, HepG2 and RPTEC/TERT1. Cells were exposed to a broad range of concentrations of 20 ETC-inhibiting agrochemicals and capsaicin, consisting of inhibitors of NADH dehydrogenase (Complex I, CI), succinate dehydrogenase (Complex II, CII) and cytochrome bc1 complex (Complex III, CIII). A battery of tests was utilised, including viability assays, lactate production, mitochondrial membrane potential (MMP) and the Seahorse bioanalyser, which simultaneously measures extracellular acidification rate [ECAR] and oxygen consumption rate [OCR]. CI inhibitors caused a potent decrease in OCR, decreased mitochondrial membrane potential, increased ECAR and increased lactate production in both cell types. Twenty-fourhour exposure to CI inhibitors decreased viability of RPTEC/TERT1 cells and 3D spheroid-cultured HepG2 cells in the presence of glucose. CI inhibitors decreased 2D HepG2 viability only in the absence of glucose. CII inhibitors had no notable effects in intact cells up to 10 µM. CIII inhibitors had similar effects to the CI inhibitors. Antimycin A was the most potent CIII inhibitor, with activity in the nanomolar range. The proposed CIII inhibitor cyazofamid demonstrated a mitochondrial uncoupling signal in both cell types. The study presents a comprehensive example of a mitochondrial assessment workflow and establishes measurable key events of ETC inhibition.
- 18 July 2020
- Published by Springer Nature in Archives of Toxicology
- Vol. 94 (8) , 2707-2729
Open AccessMultiparametric assessment of mitochondrial respiratory inhibition in HepG2 and RPTEC/TERT1 cells using a panel of mitochondrial targeting agrochemicals
Evidence is mounting for the central role of mitochondrial dysfunction in several pathologies including metabolic diseases, accelerated ageing, neurodegenerative diseases and in certain xenobiotic-induced organ toxicity. Assessing mitochondrial perturbations is not trivial and the outcomes of such investigations are dependent on the cell types used and assays employed. Here we systematically investigated the effect of electron transport chain (ETC) inhibitors on multiple mitochondrial-related parameters in two human cell types, HepG2 and RPTEC/TERT1. Cells were exposed to a broad range of concentrations of 20 ETC-inhibiting agrochemicals and capsaicin, consisting of inhibitors of NADH dehydrogenase (Complex I, CI), succinate dehydrogenase (Complex II, CII) and cytochrome bc1 complex (Complex III, CIII). A battery of tests was utilised, including viability assays, lactate production, mitochondrial membrane potential (MMP) and the Seahorse bioanalyser, which simultaneously measures extracellular acidification rate [ECAR] and oxygen consumption rate [OCR]. CI inhibitors caused a potent decrease in OCR, decreased mitochondrial membrane potential, increased ECAR and increased lactate production in both cell types. Twenty-fourhour exposure to CI inhibitors decreased viability of RPTEC/TERT1 cells and 3D spheroid-cultured HepG2 cells in the presence of glucose. CI inhibitors decreased 2D HepG2 viability only in the absence of glucose. CII inhibitors had no notable effects in intact cells up to 10 µM. CIII inhibitors had similar effects to the CI inhibitors. Antimycin A was the most potent CIII inhibitor, with activity in the nanomolar range. The proposed CIII inhibitor cyazofamid demonstrated a mitochondrial uncoupling signal in both cell types. The study presents a comprehensive example of a mitochondrial assessment workflow and establishes measurable key events of ETC inhibition.
- 1 May 2018
- Published by Elsevier in Computational Toxicology
- Vol. 6, 9-15
Creating an efficient screening model for TRPV1 agonists using conformal prediction
- 1 May 2018
- Published by Elsevier in Computational Toxicology
- Vol. 6, 9-15
Creating an efficient screening model for TRPV1 agonists using conformal prediction